Cas:92501-87-6 Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate manufacturer & supplier

We serve Chemical Name:Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate CAS:92501-87-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate

Chemical Name:Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate
CAS.NO:92501-87-6
Synonyms:Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate
Molecular Formula:C14H19NO4
Molecular Weight:265.30500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:48.00000
Exact Mass:265.13100
LogP:1.12210

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate Use and application,Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate technical grade,usp/ep/jp grade.


Related News: An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D. Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate manufacturer GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection. Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate supplier ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate vendor A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). Methyl 4-[2-(4-morpholinyl)ethoxy]benzoate factory GlaxoSmithKline��s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.